内镜下袖状胃成形术与腹腔镜袖状胃切除术的长期减重与并发症比较:系统综述与荟萃分析
该系统综述与荟萃分析纳入10项研究共7442例患者,比较内镜下袖状胃成形术(ESG)与腹腔镜袖状胃切除术(LSG)的长期减重效果及不良结局。结果显示LSG在术后24个月内减重更显著,但ESG总体不良事件及新发胃食管反流病(GERD)风险更低。
要点
- LSG在6、12、24个月减重优于ESG,但ESG不良事件及新发GERD风险更低。
- ESG可作为希望避免较高手术风险或已有GERD患者的潜在选择。
- 两组平均随访32.1个月,ESG减重效果中等但安全性更优。
核心结论
- LSG在术后两年内减重优于ESG,但ESG总体不良事件及新发GERD风险显著更低。
研究设计与样本
- 系统综述与荟萃分析,检索Ovid MEDLINE、Ovid Embase、Scopus、Web of Science Core Collection和Cochrane Library,纳入10项比较ESG与LSG的研究,共7442例患者(ESG 3583例,LSG 3859例),样本量均>5,采用随机效应模型(限制性最大似然法)。
主要发现
- ESG与LSG相比,6个月总体重减轻百分比(TBWL%)平均差异为-8.34%(95%CI -10.50至-6.19,9项研究)。
- 12个月TBWL%平均差异为-12.58%(95%CI -15.47至-9.70,6项研究)。
- 24个月TBWL%平均差异为-9.81%(95%CI -14.72至-4.90,3项研究)。
- ESG总体不良事件风险更低(9项研究,RR 0.54,p=0.03)。
- ESG新发GERD风险更低(5项研究,RR 0.33,p=0.02)。
临床怎么用
- 对于希望避免较高手术风险或已有GERD的肥胖患者,ESG可作为LSG的潜在替代选择。
- 需向患者说明ESG减重效果中等,且长期(>2年)比较数据仍有限。
局限性
- 长期比较数据有限,随访时间平均32.1个月,超过24个月的研究数量较少。
- 纳入研究多为回顾性,可能存在选择偏倚和异质性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
INTRODUCTION: Laparoscopic sleeve gastrectomy (LSG) is the most common bariatric operation worldwide, with the endoscopic sleeve gastroplasty (ESG) emerging as a non-surgical bariatric procedure with comparable outcomes to LSG. Long-term comparative data of ESG to LSG are limited but increasing. The purpose of this study was to compare the long-term efficacy and adverse outcomes including rates of de novo gastro-esophageal reflux disease (GERD). METHODS: A systematic review and meta-analysis were performed comparing outcomes of ESG versus LSG using a random effects model with restricted maximum likelihood. A comprehensive search of Ovid MEDLINE, Ovid Embase, Scopus, Web of Science Core Collection, and Cochrane Library (via Wiley) was performed. Studies comparing outcomes and adverse events following primary ESG or LSG with a sample size > 5 were included. RESULTS: Of 1136 unique results, 10 studies were included, comprising 7442 patients, of whom 3583 (48%) underwent ESG and 3859 (52%) underwent LSG. Mean age was 35.5 years and mean initial BMI was 34.6 kg/m2. Most patients were female (86.2%) and mean follow-up was 32.1 months. Meta-analysis revealed ESG was associated with lower total body weight loss (TBWL%) at 6 months (9 studies, mean diff. -8.34%, 95%CI, -10.50 to -6.19), 12 months (6 studies, mean diff. - 12.58%, 95%CI -15.47 to - 9.70) and 24 months (3 studies, mean diff. -9.81%, 95%CI -14.72 to -4.90). ESG was associated with a lower risk of both overall adverse events (9 studies, RR 0.54, p = 0.03) and de novo (GERD) (5 studies, RR 0.33, p = 0.02). CONCLUSIONS: The results of this review suggest that while LSG achieves greater weight loss up to two years postoperatively, ESG still displays moderate weight loss with a significantly lower risk of both adverse events and de novo GERD, making it a potential option for patients wishing to avoid greater surgical risks or with pre-existing GERD.
引用
- LaPlante G, Cheema S, Brand B, et al. Comparing long-term weight loss and complications in endoscopic sleeve gastroplasty and laparoscopic sleeve gastrectomy: a systematic review and meta-analysis. Surg Endosc. 2026. PMID: 42722912. doi:10.1007/s00464-026-12932-0
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。